The Extract of Litsea japonica Reduced the Development of Diabetic Nephropathy via the Inhibition of Advanced Glycation End Products Accumulation in dbdb Mice

Abstract EN

Increasing evidence indicates that advanced glycation end products (AGEs) contribute to the pathogenesis of diabetic nephropathy.

The aim of this study was to investigate the protective effect of L.

japonica extract (LJE) against renal damage in the db/db mouse.

LJE (100 or 250 mg/kg per day) was given to diabetic mice for 12 weeks.

Body weight, blood glucose levels, glycated hemoglobin (HbA1c) levels, and proteinuria were examined.

In in vitro assay of the inhibition of AGE formation, immunohistochemical analysis of podocyte loss and AGE accumulations were performed.

In 20-week-old db/db mice, severe hyperglycemia developed, and proteinuria was significantly increased.

Diabetes induced markedly morphological alterations to the renal glomerular cells.

AGE accumulations and podocyte loss were detected in renal glomeruli.

LJE treatment significantly reduced proteinuria and AGE accumulations in diabetic mice.

Moreover, the loss of nephrin, an important slit diaphragm component in the kidneys, was restored by LJE treatment.

Our studies suggest that LJE might be beneficial for the treatment of diabetic nephropathy.

The ability of LJE to attenuate proteinuria and podocyte dysfunction may be mediated by the inhibition of AGE accumulation in the context of diabetic nephropathy in db/db mice.